By Wendy Van Sickle
Columbus, Ohio, March 8 – Citigroup Global Markets Holdings Inc. priced $2.8 million of 5.9% autocallable equity-linked securities due March 24, 2022 tied to the common stock of CVS Health Corp., according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
Interest is payable quarterly.
The notes will be automatically redeemed at par plus the coupon if the shares close at or above the initial price on any quarterly observation date after six months.
The payout at maturity will be par if the stock finishes above its 77% barrier level.
Otherwise, investors will receive 14.20051 shares of the stock.
Citigroup Global Markets Inc. is the agent.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Autocallable equity-linked securities
|
| Underlying stock: | CVS Health Corp.
|
| Amount: | $2,796,000
|
| Maturity: | March 24, 2022
|
| Coupon: | 5.9%, payable quarterly
|
| Price: | Par
|
| Payout at maturity: | Par if stock closes above final barrier level; otherwise, 14.20051 CVS shares
|
| Call: | At par plus the coupon if shares close at or above the initial price any quarterly observation date after six months
|
| Initial price: | $70.42
|
| Final barrier level: | $54.223, 77% of initial price
|
| Pricing date: | Feb. 19
|
| Settlement date: | Feb. 24
|
| Agent: | Citigroup Global Markets Inc.
|
| Fees: | 2.15%
|
| Cusip: | 17328NFG8
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
